Literature DB >> 20040163

NICE work: how NICE decides what we should pay for.

John W Stevens.   

Abstract

Mesh:

Year:  2010        PMID: 20040163      PMCID: PMC2801782          DOI: 10.3399/bjgp10X482040

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  4 in total

Review 1.  Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.

Authors:  A O'Hagan; J W Stevens; J Montmartin
Journal:  Pharmacoeconomics       Date:  2000-04       Impact factor: 4.981

2.  ICH harmonized tripartite guideline: Guideline for Good Clinical Practice.

Authors: 
Journal:  J Postgrad Med       Date:  2001 Jan-Mar       Impact factor: 1.476

3.  Effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings.

Authors: 
Journal:  Br J Gen Pract       Date:  2010-01       Impact factor: 5.386

4.  Cost-effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings.

Authors: 
Journal:  Br J Gen Pract       Date:  2010-01       Impact factor: 5.386

  4 in total
  2 in total

1.  Characteristics of Cost-effectiveness Studies for Oncology Drugs Approved in the United States From 2015-2020.

Authors:  Alyson Haslam; Mark P Lythgoe; Emma Greenstreet Akman; Vinay Prasad
Journal:  JAMA Netw Open       Date:  2021-11-01

2.  Behavioral Intervention Components Associated With Cost-effectiveness: A Comparison of Six Domains.

Authors:  E Beard; F Lorencatto; B Gardner; S Michie; L Owen; L Shahab
Journal:  Ann Behav Med       Date:  2022-02-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.